Northern Trust’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History

Northern Trust’s Portfolio YTEN Stock Details YTEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1	Closed	-$35K	–	4291
2015 Q1	$35K	Hold	1	–	–	﹤0.01%	4190
2014 Q4	$23K	Hold	1	–	–	﹤0.01%	4171
2014 Q3	$51K	Hold	1	–	–	﹤0.01%	4141
2014 Q2	$49K	Hold	1	–	–	﹤0.01%	4117
2014 Q1	$75K	Hold	1	–	–	﹤0.01%	3997
2013 Q4	$80K	Hold	1	–	–	﹤0.01%	3906
2013 Q3	$80K	Hold	1	–	–	﹤0.01%	3851
2013 Q2	$90K	Buy	+1	New	+$96.7K	﹤0.01%	3822

Other funds holding YTEN

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FCG Advisors Chatham, New Jersey $425M AUM 12.09% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MCM

McRae Capital Management Morristown, New Jersey $508M AUM 14.21% 1-Year Est. Return

Northern Trust's YTEN Position: Q2 2015 in Review

Northern Trust sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q2 2015, closing a stake of 1 share — an estimated $35K sold.

Northern Trust first reported a position in YTEN in Q2 2013 and held it in 8 quarters. The position peaked at $90K in Q2 2013. 11 funds tracked by Wall St. Rank hold YTEN as of Q2 2015.

Northern Trust reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q2 2015 after selling out during the quarter.
Northern Trust sold 1 Yield10 Bioscience, Inc. Common Stock share in Q2 2015, an estimated $35K.
Northern Trust first reported a position in Yield10 Bioscience, Inc. Common Stock in Q2 2013 and held it in 8 quarters.
Northern Trust's Yield10 Bioscience, Inc. Common Stock position peaked at $90K in Q2 2013.
11 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q2 2015.

Based on Northern Trust's 13F filing for Q2 2015, filed 13 Aug 2015.